<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METAPROTERENOL SULFATE</span><br/>(met-a-proe-ter'e-nole)<br/><span class="topboxtradename">Alupent, </span><span class="topboxtradename">Metaprel<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic agonist</span>; <span class="classification">bronchodilator</span><br/><b>Prototype: </b>Albuterol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 20 mg tablet; 10 mg/5 mL syrup; 75 mg, 150 mg metered dose inhaler; 0.4%, 0.6%, 5% solution for inhalation</p>
<h1><a name="action">Actions</a></h1>
<p>Potent synthetic sympathomimetic amine similar to isoproterenol in chemical structure and pharmacologic actions. Acts selectively
         on beta<sub>2</sub>-adrenergic receptors to relax smooth muscle of bronchi, uterus, and blood vessels supplying skeletal muscles.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Bronchodilator; controls bronchospasm in asthmatics.</p>
<h1><a name="uses">Uses</a></h1>
<p>Bronchodilator in symptomatic relief of asthma and reversible bronchospasm associated with bronchitis and emphysema.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Treatment and prophylaxis of heart block and to avert progress of premature labor (tocolytic action).</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Sensitivity to other sympathomimetic agents; cardiac arrhythmias associated with tachycardia; hyperthyroidism; pregnancy (category
         C), lactation. Safety in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Older adults; hypertension, cardiovascular disorders including coronary artery disease; hyperthyroidism; diabetes.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Bronchospasm</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 20 mg q68h <span class="rdroute">Metered Dose Inhaler</span> 23 inhalations q34h (max: 12 inhalations/d) <span class="rdroute">Nebulizer</span> 510 inhalations of undiluted 5% solution <span class="rdroute">IPPB</span> 2.5 mL of 0.40.6% solution q46h<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 10 mg 34 times/d, may increase to 20 mg 34 times/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 2 y, 0.4 mg/kg t.i.d.q.i.d.; <i>26 y,</i> 1.22.6 mg/kg/d in 34 divided doses; <i>69 y</i>, 10 mg q68h; <i>&gt;9 y,</i> 20 mg q68h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<ul>
<li>
            				Note: Patient may use tablets and aerosol concomitantly.
            			
         </li>
</ul><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food to reduce GI distress.</li>
</ul><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Instruct patient to shake metered dose aerosol container, exhale through nose as completely as possible, administer aerosol
            while inhaling deeply through mouth, and to hold breath about 10 sec before exhaling slowly. Administer second inhalation
            10 min after first.
         </li>
<li>Store all forms at 15°30° C (59°86° F); protect from light and heat.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Nervousness, weakness, drowsiness, <span class="speceff-common">tremor (particularly after PO administration),</span> headache, fatigue. <span class="typehead">CV:</span>
<span class="speceff-common">Tachycardia,</span> hypertension, <span class="speceff-life">cardiac arrest</span>, palpitation. <span class="typehead">GI:</span> Nausea, vomiting, bad taste. <span class="typehead">Urogenital:</span> Occasional difficulty in micturition and muscle cramps. <span class="typehead">Respiratory:</span> Throat irritation, cough, exacerbation of asthma. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<b>Epinephrine</b> other <span class="classification">sympathomimetic bronchodilators</span> may compound effects of metaproterenol; <span class="classification">mao inhibitors</span>, <span class="classification">tricyclic antidepressants</span> potentiate action of metaproterenol on vascular system; the effects of both metaproterenol and <span class="classification">beta-adrenergic blockers</span> are antagonized. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 40% of PO doses reach systemic circulation. <span class="typehead">Onset:</span> Inhaled: 1 min; PO 15 min. <span class="typehead">Peak:</span> 1 h all routes. <span class="typehead">Duration:</span> Inhaled: 15 h; PO 4 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor respiratory status. Auscultate lungs before and after inhalation to determine efficacy of drug in decreasing airway
            resistance.
         </li>
<li>Monitor cardiac status. Report tachycardia and hypotension.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report failure to respond to usual dose. Drug may have shorter duration of action after long-term use.</li>
<li>Do not increase dose or frequency unless ordered by physician; there is the possibility of serious adverse effects.</li>
<li>Anticipate tremor as a possible adverse effect.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>